Company Filing History:
Years Active: 2010
Title: Innovations by Peter Wikström
Introduction
Peter Wikström is a notable inventor based in Gipf-Oberfrick, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of urokinase inhibitors. His work focuses on enhancing the efficacy of these compounds in treating various diseases, including cancer.
Latest Patents
Wikström holds a patent for "Urokinase inhibitors," which describes new urokinase inhibitors featuring a triisopropylphenylsulfonyl residue as an Nα-substituent for 3-amidinophenylalanine. The introduction of this residue significantly increases the compounds' affinity for urokinase, thereby enhancing their inhibitory activity. These inhibitors are particularly useful in understanding the role of urokinase and its receptor in diseases, especially in tumor propagation and metastasis. The patent also includes methods for treating tumors and a pharmaceutical composition.
Career Highlights
Wikström is associated with Wilex AG, a company that focuses on developing innovative cancer therapies. His work has been instrumental in advancing the understanding of urokinase's role in cancer biology.
Collaborations
He has collaborated with notable colleagues, including Helmut Vieweg and Jörg Stürzebecher, to further his research and development efforts in the pharmaceutical industry.
Conclusion
Peter Wikström's innovative work in developing urokinase inhibitors showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing fight against cancer and highlight the importance of research in pharmaceuticals.